Zihan Lin

The establishment of a hub differential gene model to predict prognosis in stage II and III right- and left-sided colon cancer patients.

Chuan-feng Ke, Youli Zhou, Zihan Lin, 2021, Annals of translational medicine.

MET overexpression and amplification define a distinct molecular subgroup for targeted therapies in gastric cancer

R. Rosell, Jia Wei, Baorui Liu, 2016, Gastric Cancer.

DNA hypermethylation-induced miR-182 silence targets BCL2 and HOXA9 to facilitate the self-renewal of leukemia stem cell, accelerate acute myeloid leukemia progression, and determine the sensitivity of BCL2 inhibitor venetoclax

Haige Ye, Shenmeng Gao, Liuzhi Shi, 2023, Theranostics.